Shanghai Kindly Medical Instruments Co., Ltd. (01501.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

6.6x

Market Cap

HKD 5.65B

MomentumView details →

1D Return

−3.26%

YTD Return

+14.74%

RSI (14)

54.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

6.6x

Market Cap

HKD 5.65B

RSI (14)

54.0

MomentumView details →

1D Return

−3.26%

YTD Return

+14.74%

ProfitabilityView details →

Gross Margin

60.91%

Net Margin

19.83%

EBITDA Margin

31.02%

ROE (TTM)

15.21%

ROA (TTM)

10.81%

Asset Turnover

0.60x

GrowthView details →

Revenue YoY

+40.32%

EPS YoY

+13.71%

FCF YoY

+2579.37%

Revenue CAGR 3Y

+22.06%

EPS CAGR 3Y

+16.84%

EBITDA YoY

+45.23%

EarningsView details →

EPS (Actual)

HKD 0.62

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.26x

Current Ratio

1.82x

Quick Ratio

1.60x

Div Yield

0.76%

Div Rate

HKD 0.26

Div Growth 1Y

−13.33%

Financials snapshotView financials →

Revenue (TTM)

2.11B

Net Income (TTM)

418.96M

Op. CF (TTM)

466.99M

Next earningsMar 22, 2027 →

Latest newsMore news →

Yingtai Medical (01501.HK) announced its interim results for the six months ended June 2026, with revenue of RMB 596 million, up 29.3% year-on-year, and net profit of RMB 110 million, up 12%, with earnings per share of RMB 0.54, and no dividend declared.11d ago

Similar companies

Stevanato Group S.p.A.STVN Teleflex IncorporatedTFX Merit Medical Systems, Inc.MMSI Bausch + Lomb CorporationBLCO Haemonetics CorporationHAE 天智航-U688277.SH Find similar companies →

Latest newsMore news →

Yingtai Medical (01501.HK) announced its interim results for the six months ended June 2026, with revenue of RMB 596 million, up 29.3% year-on-year, and net profit of RMB 110 million, up 12%, with earnings per share of RMB 0.54, and no dividend declared.11d ago